Also trades as: 0H7S.L (LSE)

$381.02

Last traded 2022-12-23 — delisted

NASDAQ · Healthcare · Medical - Devices · $17.2B mcap

Revenue

$1.0B +21.7% ▲

5Y CAGR: +18.3%

Gross Profit

$844M +23.0% ▲

5Y CAGR: +17.6%

Operating Income

$373M +62.4% ▲

5Y CAGR: +32.8%

Net Income

$137M -39.5% ▼

5Y CAGR: +21.2%

EPS (Diluted)

$2.98 -39.7% ▼

5Y CAGR: +20.6%

EBITDA

$500M +62.3% ▲

5Y CAGR: +39.5%

View Full Income Statement

Line Item	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	$594M	$769M	$841M	$848M	$1.0B
YoY Growth	+33.3%	+29.6%	+9.3%	+0.8%	+21.7%
Cost of Revenue	$99M	$130M	$151M	$162M	$188M
Gross Profit	$495M	$640M	$690M	$686M	$844M
Gross Margin	83.4%	83.2%	82.0%	80.9%	81.8%
R&D Expenses	$75M	$94M	$99M	$122M	$163M
SG&A Expenses	$263M	$322M	$342M	$334M	$423M
Operating Expenses	$338M	$415M	$440M	$456M	$587M
Operating Income	$157M	$225M	$249M	$230M	$373M
Operating Margin	26.5%	29.2%	29.6%	27.1%	36.1%
Interest Expense	$0	$0	$0	$0	$50M
Income Before Tax	$160M	$263M	$257M	$288M	$191M
Tax Expense	$48M	$4M	$54M	$63M	$54M
Net Income	$112M	$259M	$203M	$226M	$137M
Net Margin	18.9%	33.7%	24.1%	26.6%	13.2%
EPS (Diluted)	$2.45	$5.61	$4.43	$4.94	$2.98
EBITDA	$164M	$231M	$257M	$247M	$500M
Shares Outstanding	46M	46M	46M	46M	46M

Line Item	FY2021 Q3	FY2021 Q4	FY2022 Q1	FY2022 Q2	FY2022 Q3	FY2022 Q4	FY2023 Q1	FY2023 Q2
Revenue	$232M	$241M	$253M	$248M	$261M	$270M	$277M	$266M
Cost of Revenue	$41M	$46M	$45M	$44M	$48M	$51M	$53M	$49M
Gross Profit	$191M	$195M	$207M	$204M	$214M	$218M	$225M	$217M
Gross Margin	82.3%	80.9%	82.1%	82.3%	81.8%	80.9%	81.0%	81.6%
R&D Expenses	$33M	$32M	$38M	$41M	$41M	$44M	$40M	$42M
SG&A Expenses	$86M	$100M	$103M	$103M	$108M	$110M	$118M	$117M
Operating Expenses	$119M	$132M	$141M	$144M	$148M	$153M	$158M	$159M
Operating Income	$71M	$63M	-$49M	$60M	$65M	$65M	$66M	$58M
Operating Margin	30.8%	26.0%	-19.5%	24.4%	24.7%	24.1%	23.8%	21.8%
Interest Expense	$0	$0	$0	$0	$0	$10M	$4M	$81M
Income Before Tax	$81M	$73M	-$9M	$67M	$58M	$75M	$70M	$139M
Tax Expense	$19M	$17M	$17M	$10M	$12M	$14M	$15M	$33M
Net Income	$62M	$57M	-$27M	$57M	$46M	$60M	$55M	$106M
Net Margin	26.7%	23.6%	-10.5%	23.0%	17.5%	22.4%	19.7%	39.9%
EPS (Diluted)	$1.35	$1.24	$-0.59	$1.24	$1.00	$1.31	$1.19	$2.32
EBITDA	$76M	$69M	$188M	$66M	$72M	$92M	$80M	$226M
Shares Outstanding	46M	46M	45M	46M	46M	46M	46M	46M

ABMD NASDAQ